138 related articles for article (PubMed ID: 28214877)
21. Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells.
Chen LJ; Ye H; Zhang Q; Li FZ; Song LJ; Yang J; Mu Q; Rao SS; Cai PC; Xiang F; Zhang JC; Su Y; Xin JB; Ma WL
Toxicol Appl Pharmacol; 2015 Mar; 283(2):75-82. PubMed ID: 25595642
[TBL] [Abstract][Full Text] [Related]
22. Cigarette smoke-induced alveolar epithelial-mesenchymal transition is mediated by Rac1 activation.
Shen HJ; Sun YH; Zhang SJ; Jiang JX; Dong XW; Jia YL; Shen J; Guan Y; Zhang LH; Li FF; Lin XX; Wu XM; Xie QM; Yan XF
Biochim Biophys Acta; 2014 Jun; 1840(6):1838-49. PubMed ID: 24508121
[TBL] [Abstract][Full Text] [Related]
23. Early events in the pathogenesis of chronic obstructive pulmonary disease. Smoking-induced reprogramming of airway epithelial basal progenitor cells.
Shaykhiev R; Crystal RG
Ann Am Thorac Soc; 2014 Dec; 11 Suppl 5(Suppl 5):S252-8. PubMed ID: 25525728
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma.
Hackett TL
Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):53-9. PubMed ID: 22217512
[TBL] [Abstract][Full Text] [Related]
25. [Apoptosis of alveolar epithelial cells and pulmonary vascular endothelial cells in chronic obstructive pulmonary disease].
Liu SK; Chen P; Chen JB
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):581-5. PubMed ID: 19080401
[TBL] [Abstract][Full Text] [Related]
26. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
[TBL] [Abstract][Full Text] [Related]
27. Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway.
Figeac F; Dagouassat M; Mahrouf-Yorgov M; Le Gouvello S; Trébeau C; Sayed A; Stern JB; Validire P; Dubois-Randé JL; Boczkowski J; Mus-Veteau I; Rodriguez AM
PLoS One; 2015; 10(3):e0121579. PubMed ID: 25815884
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-mesenchymal transition: a key mechanism for cigarette smoke-associated pulmonary fibrosis in COPD?
Wang H; Liao Z; Wan C; Wen F; Chen L
Eur J Intern Med; 2015 Mar; 26(2):143. PubMed ID: 25577309
[No Abstract] [Full Text] [Related]
29. [Cell senescence and pathophysiology of chronic lung diseases: role in chronic obstructive pulmonary disease].
Adnot S
Bull Acad Natl Med; 2014; 198(4-5):659-71. PubMed ID: 26753399
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
[TBL] [Abstract][Full Text] [Related]
31. Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies.
Eapen MS; Sharma P; Thompson IE; Lu W; Myers S; Hansbro PM; Sohal SS
Lab Invest; 2019 Feb; 99(2):150-157. PubMed ID: 30451982
[TBL] [Abstract][Full Text] [Related]
32. Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic obstructive pulmonary disease.
Jin Z; Pan X; Zhou K; Bi H; Wang L; Yu L; Wang Q
J Int Med Res; 2015 Jun; 43(3):303-10. PubMed ID: 25834280
[TBL] [Abstract][Full Text] [Related]
33. ERK5 negatively regulates tobacco smoke-induced pulmonary epithelial-mesenchymal transition.
Liang Z; Xie W; Wu R; Geng H; Zhao L; Xie C; Li X; Huang C; Zhu J; Zhu M; Zhu W; Wu J; Geng S; Zhong C
Oncotarget; 2015 Aug; 6(23):19605-18. PubMed ID: 25965818
[TBL] [Abstract][Full Text] [Related]
34. IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
Roos AB; Sandén C; Mori M; Bjermer L; Stampfli MR; Erjefält JS
Am J Respir Crit Care Med; 2015 Jun; 191(11):1232-41. PubMed ID: 25844618
[TBL] [Abstract][Full Text] [Related]
35. sE-cadherin and sVE-cadherin indicate active epithelial/endothelial to mesenchymal transition (EMT and EndoMT) in smokers and COPD: implications for new biomarkers and therapeutics.
Eapen MS; Myers S; Lu W; Tanghe C; Sharma P; Sohal SS
Biomarkers; 2018 Nov; 23(7):709-711. PubMed ID: 29781727
[No Abstract] [Full Text] [Related]
36. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.
Yamada A; Aki T; Unuma K; Funakoshi T; Uemura K
PLoS One; 2015; 10(3):e0120192. PubMed ID: 25799450
[TBL] [Abstract][Full Text] [Related]
37. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease.
van Eeden SF; Sin DD
Respiration; 2008; 75(2):224-38. PubMed ID: 18042978
[TBL] [Abstract][Full Text] [Related]
38. Considerations and pitfalls in phenotyping and reclassification of chronic obstructive pulmonary disease.
Bon J; Liao S; Tseng G; Sciurba FC
Transl Res; 2013 Oct; 162(4):252-7. PubMed ID: 23920431
[TBL] [Abstract][Full Text] [Related]
39. Sirtuin 1 and aging theory for chronic obstructive pulmonary disease.
Conti V; Corbi G; Manzo V; Pelaia G; Filippelli A; Vatrella A
Anal Cell Pathol (Amst); 2015; 2015():897327. PubMed ID: 26236580
[TBL] [Abstract][Full Text] [Related]
40. The small airways in chronic obstructive pulmonary disease: pathology and effects on disease progression and survival.
Stewart JI; Criner GJ
Curr Opin Pulm Med; 2013 Mar; 19(2):109-15. PubMed ID: 23325030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
